News

Medscape1d
Unprecedented Case of Rhabdomyoma in a Young Boy
A rare case of adult rhabdomyoma in a child’s pharyngeal region is successfully diagnosed and treated surgically, with no ...
Cancer Therapy Advisor1d
Reduced Radiotherapy Dose Deemed Standard for Head and Neck Cancer
The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...
Le Lézard21h
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
AbbVie  today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe ...
ascopubs.org4d
Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline Clinical Insights
Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring ...
Targeted Oncology3d
Novel CAR T Therapy Earns FDA Breakthrough Status for Incurable Pediatric Brain Tumor
The FDA has granted breakthrough therapy designation to BCB-276 for the treatment of diffuse intrinsic pontine glioma (DIPG), an incurable pediatric brain tumor. BCB-276 is an investigational chimeric ...
emjreviews.com3d
What Physicians Need to Know Before Recommending TORS
IN a significant update for head and neck oncology care, new clinical insights into transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPC) aim to guide U.S. physicians in ...